Klaus Pietzner
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 39
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 11
-
- PARP inhibition in cancer therapy 6
-
- Rheumatoid Arthritis Research and Therapies 8
- Systemic Lupus Erythematosus Research 5
-
- Intraperitoneal and Appendiceal Malignancies 16
-
- Cardiac, Anesthesia and Surgical Outcomes 7
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Jalid SehouliChristina FotopoulouElena Ioana BraicuRolf RichterJ. DetertCarsten DenkertSilvia Darb‐EsfahaniHannah Woopen
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Klaus Pietzner
75 papers receiving 766 citations
Peers
Comparison fields: 5 of 85
- Reproductive Medicine 248
- Obstetrics and Gynecology 117
- Oncology 222
- Rheumatology 80
- Surgery 223
Countries citing papers authored by Klaus Pietzner
This map shows the geographic impact of Klaus Pietzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Pietzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Pietzner more than expected).
Fields of papers citing papers by Klaus Pietzner
This network shows the impact of papers produced by Klaus Pietzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Pietzner. The network helps show where Klaus Pietzner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Klaus Pietzner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 0 | |
| 14 | 2022 | 6 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 3 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 24 | |
| 19 | Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany. | 2016 | 27 |
| 20 | 2006 | 47 |
About Klaus Pietzner
Klaus Pietzner is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 91 papers that have together received 782 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (39 papers), Intraperitoneal and Appendiceal Malignancies (16 papers), Endometrial and Cervical Cancer Treatments (11 papers), Rheumatoid Arthritis Research and Therapies (8 papers), Cardiac, Anesthesia and Surgical Outcomes (7 papers), PARP inhibition in cancer therapy (6 papers), Cancer Genomics and Diagnostics (5 papers) and Systemic Lupus Erythematosus Research (5 papers). The work is most often cited by research in Reproductive Medicine (248 citations), Obstetrics and Gynecology (117 citations) and Oncology (222 citations). Klaus Pietzner has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Jalid Sehouli, Christina Fotopoulou, Elena Ioana Braicu, Rolf Richter, J. Detert, Carsten Denkert, Silvia Darb‐Esfahani, Hannah Woopen, Ralf P. Richter and Mustafa Zelal Muallem. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.